Global Artificial Insemination Market Research Report—Forecast till 2027
Global Artificial Insemination Market was valued at USD 1,818.29 Million in 2019 and is expected to register a CAGR of 8.6% during the forecast period of 2020 to 2027. An expanding number of medical insurance agencies offering inclusion for couples of equivalent genders is probably expected to attain the growth for the global artificial insemination market to develop. The rising mindfulness about barrenness and the potential medicines like artificial insemination, IVF, and other novel methods increment the fruitfulness rate for different nations. The government support through repayment and co-pay system is expected to raise the number of manufacturers entering the market in developing countries.
The global artificial insemination market is expected to register significant market growth during the review period. The global market growth is driven by the rising infertility rate in the world and changing lifestyles. Moreover, the developing regulatory scenarios related to artificial insemination and technological developments in artificial insemination are expected to drive the global market during the review period. Additionally, the rising fertility-related disorders are one of the prime factors contributing to the growth of artificial insemination.
Global Artificial Insemination Market has been divided based on Type and End User.
Based on type segment, the global artificial insemination market has been divided into intrauterine, intracervical, and intratubal. The increasing prevalence of infertility and technological advancements in artificial insemination are driving the growth of the market. As per the World Health Organization, around 48 million couples were living with infertility globally as of September 2020.
Based on the end-user segment, the global artificial insemination market has been classified as hospitals & clinics, fertility centers, and home-based. The hospitals & clinics segment dominated the global artificial insemination market in 2019. Its large share of 49.0% is attributable to a rising preference for insemination procedures in clinics.
Geographically, Global Artificial Insemination Market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is expected to lead the global artificial insemination market owing to the largest market share of 40.8% in 2019. The regional market is attributed to the large number of companies operating in the region. Additionally, the government regulations and healthcare expenditure by the countries in the region are fuelling the market growth during the review period. Europe held a prominent share in the global artificial insemination market followed by the Asia Pacific during the review period.
The Key Players in the Global Artificial Insemination Market are Vitrolife AB, Genea Limited, Rinovum Women’s Health, LLC, Pride Angel, Hi-tech Solutions, Kitazato Corporation, Fujifilm Irvine Scientific, and Rocket Medical.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.